tiprankstipranks
Neurocrine price target raised to $182 from $172 at BofA
PremiumThe FlyNeurocrine price target raised to $182 from $172 at BofA
1M ago
Neurocrine says Crenessity now available in U.S.
Premium
The Fly
Neurocrine says Crenessity now available in U.S.
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Neurocrine presents data from Ingrezza studies on tardive dyskines patients
PremiumThe FlyNeurocrine presents data from Ingrezza studies on tardive dyskines patients
3M ago
Neurocrine presents data from long-term KINECT-4 study
Premium
The Fly
Neurocrine presents data from long-term KINECT-4 study
3M ago
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
Premium
Company Announcements
Neurocrine Biosciences’ $300M Share Buyback Plan: Potential Risks and Market Volatility Concerns
3M ago
NBIX Earnings this Week: How Will it Perform?
PremiumPre-EarningsNBIX Earnings this Week: How Will it Perform?
3M ago
AbbVie price target raised to $195 from $185 at BofA
Premium
The Fly
AbbVie price target raised to $195 from $185 at BofA
3M ago
Neurocrine price target lowered to $114 from $128 at BMO Capital
Premium
The Fly
Neurocrine price target lowered to $114 from $128 at BMO Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100